Bindu Narang

Bindu Narang is an accomplished executive in the field of patient safety and drug safety, currently serving as Executive Director of Patient Safety at Fortrea since May 2023. With extensive experience in drug development, Bindu has previously held significant leadership roles, including Executive Director of Drug Safety at Labcorp Drug Development from October 2012 to June 2023 and Senior Director at Covance from January 2020 to April 2021, overseeing medical writing, regulatory affairs, and risk management. Bindu also contributed to business operations and change management at i3statprobe (inVentiv) as Associate Director from June 2007 to October 2012, and established a global medical writing team at Pfizer from October 2004 to June 2007. Bindu's career began in sales promotion at UCB from 1993 to 1998. Educationally, Bindu holds a Master's degree in Medicinal and Pharmaceutical Chemistry from PKMK College of Pharmacy, completed in 1988.